Table 4.
The effect of treatments on Salmonella enterica subsp. enterica serovar Infantis population (Log10 cfu*/g) of cecal content and liver tissue.
| Treatments | Age (D) |
||
|---|---|---|---|
| 7 | 14 | 21 | |
| Cecum | |||
| S | 9.24 ± 0.20a | 6.82 ± 0.35a | 4.36 ± 0.15a |
| SA | 7.73 ± 0.89c | 3.66 ± 0.37c | 0.48 ± 0.24e |
| SIPY | 8.89 ± 0.57a,b | 6.39 ± 0.32a | 3.83 ± 0.22b,c |
| SCIY | 8.51 ± 0.83a,b | 4.82 ± 0.28b | 1.60 ± 0.27d |
| SIWY | 8.89 ± 0.50a,b | 6.61 ± 0.45a | 3.74 ± 0.45c |
| SNIPY | 9.10 ± 0.56a,b | 6.86 ± 0.33a | 4.23 ± 0.39a,b |
| SNIWY | 9.20 ± 0.37a,b | 6.87 ± 0.41a | 4.25 ± 0.28a,b |
| C | 0.0 ± 0.0d | 0.0 ± 0.0d | 0.0 ± 0.0f |
| P-value | 0.0001 | 0.0001 | 0.0001 |
| Treatments | Liver | ||
| S | 5.39 ± 0.27a | 3.85 ± 0.64a | 1.74 ± 0.56a |
| SA | 2.47 ± 0.19c | 0.08 ± 0.11c | 0.0 ± 0.0b |
| SIPY | 5.07 ± 0.51a | 3.43 ± 0.72a | 1.6 ± 0.45a |
| SCIY | 3.46 ± 0.79b | 1.47 ± 0.38b | 0.0 ± 0.0b |
| SIWY | 5.21 ± 0.26a | 3.68 ± 1.24a | 1.54 ± 0.43a |
| SNIPY | 5.49 ± 0.27a | 3.97 ± 0.71a | 1.69 ± 0.48a |
| SNIWY | 5.13 ± 0.29a | 3.78 ± 0.99a | 1.71 ± 0.32a |
| C | 0.0 ± 0.0d | 0.0 ± 0.0c | 0.0 ± 0.0b |
| P-value | 0.0001 | 0.0001 | 0.0001 |
a-bMeans within a column lacking a common superscripts differ (P < 0.01).
Abbreviations: S, Salmonella challenged groups; SA, Salmonella antibiotic; SIPY, Salmonella immune powdered yolk; SCIY, Salmonella capsulated immune yolk; SIWY, Salmonella immune water-soluble yolk fraction; SNIWY, Salmonella nonimmune water-soluble yolk fraction; NC, negative control.
*Log CFU SI per gram of cecal content and mixed liver tissue (n = 6).
Values represent the mean ± SD.